Randhawa Simrat bought DNTH
March 12, 2026 · Form 4 insider transaction
Randhawa Simrat bought 7,998 shares of Dianthus Therapeutics, Inc. at $8.44 per share, a transaction worth $67.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
7,998
Price
$8.44
Total value
$67.5K
InsiderRandhawa Simrat
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 12, 2026
Filing dateMarch 13, 2026
Shares owned after7,998
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025.